nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—stomach cancer—pancreatic cancer	0.345	1	CtDrD
Docetaxel—EGFR—pancreatic cancer	0.16	1	CbGaD
Docetaxel—EGFR—Erlotinib—pancreatic cancer	0.0412	0.132	CbGbCtD
Docetaxel—NR1I2—Erlotinib—pancreatic cancer	0.0375	0.12	CbGbCtD
Docetaxel—ABCC10—Gemcitabine—pancreatic cancer	0.0267	0.0857	CbGbCtD
Docetaxel—CYP1B1—Tamoxifen—pancreatic cancer	0.0168	0.0541	CbGbCtD
Docetaxel—CYP1B1—Erlotinib—pancreatic cancer	0.0143	0.046	CbGbCtD
Docetaxel—ABCC10—Doxorubicin—pancreatic cancer	0.013	0.0417	CbGbCtD
Docetaxel—SLC22A7—Fluorouracil—pancreatic cancer	0.0112	0.0361	CbGbCtD
Docetaxel—ABCC1—Epirubicin—pancreatic cancer	0.00943	0.0303	CbGbCtD
Docetaxel—ABCC1—Irinotecan—pancreatic cancer	0.00917	0.0295	CbGbCtD
Docetaxel—ABCC2—Tamoxifen—pancreatic cancer	0.00884	0.0284	CbGbCtD
Docetaxel—ABCG2—Tamoxifen—pancreatic cancer	0.00799	0.0257	CbGbCtD
Docetaxel—CYP1B1—Doxorubicin—pancreatic cancer	0.00705	0.0227	CbGbCtD
Docetaxel—ABCG2—Erlotinib—pancreatic cancer	0.0068	0.0219	CbGbCtD
Docetaxel—ABCC2—Irinotecan—pancreatic cancer	0.00679	0.0218	CbGbCtD
Docetaxel—ABCG2—Irinotecan—pancreatic cancer	0.00614	0.0197	CbGbCtD
Docetaxel—CYP3A7—Tamoxifen—pancreatic cancer	0.0059	0.019	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0059	0.019	CbGbCtD
Docetaxel—ABCG2—Fluorouracil—pancreatic cancer	0.00589	0.0189	CbGbCtD
Docetaxel—ABCC1—Doxorubicin—pancreatic cancer	0.00501	0.0161	CbGbCtD
Docetaxel—ABCC2—Sunitinib—pancreatic cancer	0.00495	0.0159	CbGbCtD
Docetaxel—CYP3A7—Irinotecan—pancreatic cancer	0.00453	0.0146	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.00453	0.0146	CbGbCtD
Docetaxel—ABCG2—Sunitinib—pancreatic cancer	0.00448	0.0144	CbGbCtD
Docetaxel—CYP3A5—Tamoxifen—pancreatic cancer	0.00443	0.0142	CbGbCtD
Docetaxel—CYP3A5—Erlotinib—pancreatic cancer	0.00377	0.0121	CbGbCtD
Docetaxel—ABCC2—Doxorubicin—pancreatic cancer	0.00371	0.0119	CbGbCtD
Docetaxel—CYP3A5—Irinotecan—pancreatic cancer	0.0034	0.0109	CbGbCtD
Docetaxel—ABCG2—Doxorubicin—pancreatic cancer	0.00335	0.0108	CbGbCtD
Docetaxel—CYP3A7—Sunitinib—pancreatic cancer	0.00331	0.0106	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.00331	0.0106	CbGbCtD
Docetaxel—ABCB1—Tamoxifen—pancreatic cancer	0.00288	0.00927	CbGbCtD
Docetaxel—ABCB1—Gemcitabine—pancreatic cancer	0.00248	0.00799	CbGbCtD
Docetaxel—CYP3A5—Sunitinib—pancreatic cancer	0.00248	0.00798	CbGbCtD
Docetaxel—ABCB1—Erlotinib—pancreatic cancer	0.00245	0.00788	CbGbCtD
Docetaxel—ABCC2—bile duct—pancreatic cancer	0.00237	0.145	CbGeAlD
Docetaxel—ABCB1—Irinotecan—pancreatic cancer	0.00221	0.00712	CbGbCtD
Docetaxel—ABCC2—bile—pancreatic cancer	0.00182	0.111	CbGeAlD
Docetaxel—CYP3A4—Tamoxifen—pancreatic cancer	0.00173	0.00556	CbGbCtD
Docetaxel—ABCB1—Sunitinib—pancreatic cancer	0.00161	0.00519	CbGbCtD
Docetaxel—CYP3A4—Erlotinib—pancreatic cancer	0.00147	0.00472	CbGbCtD
Docetaxel—CYP3A4—Irinotecan—pancreatic cancer	0.00133	0.00427	CbGbCtD
Docetaxel—ABCB1—Doxorubicin—pancreatic cancer	0.00121	0.00389	CbGbCtD
Docetaxel—KIF11—Topotecan—Irinotecan—pancreatic cancer	0.000982	0.555	CbGdCrCtD
Docetaxel—CYP3A4—Sunitinib—pancreatic cancer	0.000967	0.00311	CbGbCtD
Docetaxel—NR1I2—digestive system—pancreatic cancer	0.000792	0.0484	CbGeAlD
Docetaxel—CYP3A4—Doxorubicin—pancreatic cancer	0.000724	0.00233	CbGbCtD
Docetaxel—MAP2—islet of Langerhans—pancreatic cancer	0.00068	0.0416	CbGeAlD
Docetaxel—MAP4—pancreas—pancreatic cancer	0.000607	0.0371	CbGeAlD
Docetaxel—TUBB3—digestive system—pancreatic cancer	0.000518	0.0317	CbGeAlD
Docetaxel—MAP4—digestive system—pancreatic cancer	0.000518	0.0317	CbGeAlD
Docetaxel—TUBB2B—islet of Langerhans—pancreatic cancer	0.000508	0.031	CbGeAlD
Docetaxel—TUBB—islet of Langerhans—pancreatic cancer	0.00048	0.0294	CbGeAlD
Docetaxel—TUBB2A—islet of Langerhans—pancreatic cancer	0.000478	0.0292	CbGeAlD
Docetaxel—MAP2—pancreas—pancreatic cancer	0.000478	0.0292	CbGeAlD
Docetaxel—TUBB6—islet of Langerhans—pancreatic cancer	0.000471	0.0288	CbGeAlD
Docetaxel—BCL2—digestive system—pancreatic cancer	0.000471	0.0288	CbGeAlD
Docetaxel—TUBB4B—islet of Langerhans—pancreatic cancer	0.00041	0.0251	CbGeAlD
Docetaxel—MAP2—digestive system—pancreatic cancer	0.000408	0.025	CbGeAlD
Docetaxel—TUBB4A—pancreas—pancreatic cancer	0.000369	0.0226	CbGeAlD
Docetaxel—TUBB2B—pancreas—pancreatic cancer	0.000357	0.0218	CbGeAlD
Docetaxel—SLC22A7—digestive system—pancreatic cancer	0.000353	0.0216	CbGeAlD
Docetaxel—TUBB—pancreas—pancreatic cancer	0.000338	0.0207	CbGeAlD
Docetaxel—TUBB2A—pancreas—pancreatic cancer	0.000336	0.0205	CbGeAlD
Docetaxel—TUBB6—pancreas—pancreatic cancer	0.000331	0.0203	CbGeAlD
Docetaxel—TUBB4A—digestive system—pancreatic cancer	0.000315	0.0193	CbGeAlD
Docetaxel—TUBB2B—digestive system—pancreatic cancer	0.000305	0.0186	CbGeAlD
Docetaxel—TUBB4B—pancreas—pancreatic cancer	0.000288	0.0176	CbGeAlD
Docetaxel—TUBB2A—digestive system—pancreatic cancer	0.000287	0.0175	CbGeAlD
Docetaxel—TUBB6—digestive system—pancreatic cancer	0.000283	0.0173	CbGeAlD
Docetaxel—KIF11—Cytarabine—Gemcitabine—pancreatic cancer	0.000249	0.141	CbGdCrCtD
Docetaxel—ABCC10—digestive system—pancreatic cancer	0.000248	0.0152	CbGeAlD
Docetaxel—TUBB4B—digestive system—pancreatic cancer	0.000246	0.015	CbGeAlD
Docetaxel—CYP3A5—islet of Langerhans—pancreatic cancer	0.000224	0.0137	CbGeAlD
Docetaxel—TUBB6—Zalcitabine—Gemcitabine—pancreatic cancer	0.000222	0.126	CbGdCrCtD
Docetaxel—ABCC2—digestive system—pancreatic cancer	0.000199	0.0122	CbGeAlD
Docetaxel—CYP1B1—digestive system—pancreatic cancer	0.000195	0.0119	CbGeAlD
Docetaxel—CYP3A5—pancreas—pancreatic cancer	0.000158	0.00964	CbGeAlD
Docetaxel—CYP3A5—digestive system—pancreatic cancer	0.000135	0.00823	CbGeAlD
Docetaxel—ABCB1—islet of Langerhans—pancreatic cancer	0.000119	0.00729	CbGeAlD
Docetaxel—TUBB—Azacitidine—Gemcitabine—pancreatic cancer	0.000113	0.0639	CbGdCrCtD
Docetaxel—CYP3A4—digestive system—pancreatic cancer	0.000101	0.00618	CbGeAlD
Docetaxel—ABCB1—pancreas—pancreatic cancer	8.37e-05	0.00512	CbGeAlD
Docetaxel—TUBB6—Clomifene—Tamoxifen—pancreatic cancer	7.92e-05	0.0447	CbGdCrCtD
Docetaxel—TUBB6—Toremifene—Tamoxifen—pancreatic cancer	7.74e-05	0.0437	CbGdCrCtD
Docetaxel—ABCB1—digestive system—pancreatic cancer	7.15e-05	0.00437	CbGeAlD
Docetaxel—TUBB6—Azacitidine—Gemcitabine—pancreatic cancer	4.67e-05	0.0264	CbGdCrCtD
Docetaxel—Nausea—Tamoxifen—pancreatic cancer	3.14e-05	0.000309	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	3.14e-05	0.000308	CcSEcCtD
Docetaxel—Fatigue—Gemcitabine—pancreatic cancer	3.13e-05	0.000308	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	3.12e-05	0.000307	CcSEcCtD
Docetaxel—Pain—Gemcitabine—pancreatic cancer	3.11e-05	0.000305	CcSEcCtD
Docetaxel—Constipation—Gemcitabine—pancreatic cancer	3.11e-05	0.000305	CcSEcCtD
Docetaxel—Nausea—Erlotinib—pancreatic cancer	3.11e-05	0.000305	CcSEcCtD
Docetaxel—Decreased appetite—Fluorouracil—pancreatic cancer	3.11e-05	0.000305	CcSEcCtD
Docetaxel—Diarrhoea—Sunitinib—pancreatic cancer	3.1e-05	0.000305	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	3.09e-05	0.000303	CcSEcCtD
Docetaxel—Ataxia—Doxorubicin—pancreatic cancer	3.08e-05	0.000303	CcSEcCtD
Docetaxel—Feeling abnormal—Irinotecan—pancreatic cancer	3.08e-05	0.000302	CcSEcCtD
Docetaxel—Dysphagia—Epirubicin—pancreatic cancer	3.06e-05	0.000301	CcSEcCtD
Docetaxel—Pain—Fluorouracil—pancreatic cancer	3.06e-05	0.0003	CcSEcCtD
Docetaxel—Gastrointestinal pain—Irinotecan—pancreatic cancer	3.05e-05	0.0003	CcSEcCtD
Docetaxel—Dehydration—Doxorubicin—pancreatic cancer	3.05e-05	0.000299	CcSEcCtD
Docetaxel—Liver function test abnormal—Doxorubicin—pancreatic cancer	3.02e-05	0.000297	CcSEcCtD
Docetaxel—Dry skin—Doxorubicin—pancreatic cancer	3e-05	0.000295	CcSEcCtD
Docetaxel—Dizziness—Sunitinib—pancreatic cancer	3e-05	0.000294	CcSEcCtD
Docetaxel—Feeling abnormal—Gemcitabine—pancreatic cancer	3e-05	0.000294	CcSEcCtD
Docetaxel—Abdominal pain upper—Doxorubicin—pancreatic cancer	2.99e-05	0.000294	CcSEcCtD
Docetaxel—Orthostatic hypotension—Doxorubicin—pancreatic cancer	2.99e-05	0.000294	CcSEcCtD
Docetaxel—Angina pectoris—Epirubicin—pancreatic cancer	2.98e-05	0.000293	CcSEcCtD
Docetaxel—Breast disorder—Doxorubicin—pancreatic cancer	2.96e-05	0.000291	CcSEcCtD
Docetaxel—Body temperature increased—Irinotecan—pancreatic cancer	2.95e-05	0.00029	CcSEcCtD
Docetaxel—Abdominal pain—Irinotecan—pancreatic cancer	2.95e-05	0.00029	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	2.95e-05	0.00029	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	2.95e-05	0.00029	CcSEcCtD
Docetaxel—Feeling abnormal—Fluorouracil—pancreatic cancer	2.95e-05	0.000289	CcSEcCtD
Docetaxel—Nasopharyngitis—Doxorubicin—pancreatic cancer	2.93e-05	0.000288	CcSEcCtD
Docetaxel—Pancytopenia—Epirubicin—pancreatic cancer	2.91e-05	0.000286	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	2.89e-05	0.000284	CcSEcCtD
Docetaxel—Vomiting—Sunitinib—pancreatic cancer	2.88e-05	0.000283	CcSEcCtD
Docetaxel—Body temperature increased—Gemcitabine—pancreatic cancer	2.87e-05	0.000282	CcSEcCtD
Docetaxel—Neutropenia—Epirubicin—pancreatic cancer	2.86e-05	0.000281	CcSEcCtD
Docetaxel—Rash—Sunitinib—pancreatic cancer	2.86e-05	0.000281	CcSEcCtD
Docetaxel—Dermatitis—Sunitinib—pancreatic cancer	2.85e-05	0.00028	CcSEcCtD
Docetaxel—Headache—Sunitinib—pancreatic cancer	2.84e-05	0.000279	CcSEcCtD
Docetaxel—Dysphagia—Doxorubicin—pancreatic cancer	2.83e-05	0.000278	CcSEcCtD
Docetaxel—Body temperature increased—Fluorouracil—pancreatic cancer	2.83e-05	0.000278	CcSEcCtD
Docetaxel—Weight increased—Epirubicin—pancreatic cancer	2.78e-05	0.000274	CcSEcCtD
Docetaxel—Weight decreased—Epirubicin—pancreatic cancer	2.77e-05	0.000272	CcSEcCtD
Docetaxel—Angina pectoris—Doxorubicin—pancreatic cancer	2.76e-05	0.000271	CcSEcCtD
Docetaxel—Hypersensitivity—Irinotecan—pancreatic cancer	2.75e-05	0.00027	CcSEcCtD
Docetaxel—Pneumonia—Epirubicin—pancreatic cancer	2.74e-05	0.00027	CcSEcCtD
Docetaxel—Infestation—Epirubicin—pancreatic cancer	2.73e-05	0.000268	CcSEcCtD
Docetaxel—Infestation NOS—Epirubicin—pancreatic cancer	2.73e-05	0.000268	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	2.7e-05	0.000266	CcSEcCtD
Docetaxel—Nausea—Sunitinib—pancreatic cancer	2.69e-05	0.000264	CcSEcCtD
Docetaxel—Pancytopenia—Doxorubicin—pancreatic cancer	2.69e-05	0.000264	CcSEcCtD
Docetaxel—Renal failure—Epirubicin—pancreatic cancer	2.68e-05	0.000264	CcSEcCtD
Docetaxel—Asthenia—Irinotecan—pancreatic cancer	2.68e-05	0.000263	CcSEcCtD
Docetaxel—Neuropathy peripheral—Epirubicin—pancreatic cancer	2.67e-05	0.000263	CcSEcCtD
Docetaxel—Stomatitis—Epirubicin—pancreatic cancer	2.66e-05	0.000261	CcSEcCtD
Docetaxel—Jaundice—Epirubicin—pancreatic cancer	2.66e-05	0.000261	CcSEcCtD
Docetaxel—Conjunctivitis—Epirubicin—pancreatic cancer	2.65e-05	0.000261	CcSEcCtD
Docetaxel—Neutropenia—Doxorubicin—pancreatic cancer	2.65e-05	0.00026	CcSEcCtD
Docetaxel—Hypersensitivity—Fluorouracil—pancreatic cancer	2.63e-05	0.000259	CcSEcCtD
Docetaxel—Asthenia—Gemcitabine—pancreatic cancer	2.61e-05	0.000256	CcSEcCtD
Docetaxel—Hepatobiliary disease—Epirubicin—pancreatic cancer	2.58e-05	0.000254	CcSEcCtD
Docetaxel—Weight increased—Doxorubicin—pancreatic cancer	2.58e-05	0.000253	CcSEcCtD
Docetaxel—Epistaxis—Epirubicin—pancreatic cancer	2.57e-05	0.000253	CcSEcCtD
Docetaxel—Pruritus—Gemcitabine—pancreatic cancer	2.57e-05	0.000253	CcSEcCtD
Docetaxel—Weight decreased—Doxorubicin—pancreatic cancer	2.56e-05	0.000252	CcSEcCtD
Docetaxel—Diarrhoea—Irinotecan—pancreatic cancer	2.55e-05	0.000251	CcSEcCtD
Docetaxel—Agranulocytosis—Epirubicin—pancreatic cancer	2.55e-05	0.00025	CcSEcCtD
Docetaxel—Pneumonia—Doxorubicin—pancreatic cancer	2.54e-05	0.000249	CcSEcCtD
Docetaxel—Pruritus—Fluorouracil—pancreatic cancer	2.53e-05	0.000248	CcSEcCtD
Docetaxel—Infestation NOS—Doxorubicin—pancreatic cancer	2.52e-05	0.000248	CcSEcCtD
Docetaxel—Infestation—Doxorubicin—pancreatic cancer	2.52e-05	0.000248	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	2.5e-05	0.000246	CcSEcCtD
Docetaxel—Diarrhoea—Gemcitabine—pancreatic cancer	2.49e-05	0.000244	CcSEcCtD
Docetaxel—Renal failure—Doxorubicin—pancreatic cancer	2.48e-05	0.000244	CcSEcCtD
Docetaxel—Neuropathy peripheral—Doxorubicin—pancreatic cancer	2.47e-05	0.000243	CcSEcCtD
Docetaxel—Dizziness—Irinotecan—pancreatic cancer	2.47e-05	0.000242	CcSEcCtD
Docetaxel—Haemoglobin—Epirubicin—pancreatic cancer	2.46e-05	0.000242	CcSEcCtD
Docetaxel—Jaundice—Doxorubicin—pancreatic cancer	2.46e-05	0.000242	CcSEcCtD
Docetaxel—Stomatitis—Doxorubicin—pancreatic cancer	2.46e-05	0.000242	CcSEcCtD
Docetaxel—Rhinitis—Epirubicin—pancreatic cancer	2.46e-05	0.000241	CcSEcCtD
Docetaxel—Conjunctivitis—Doxorubicin—pancreatic cancer	2.45e-05	0.000241	CcSEcCtD
Docetaxel—Haemorrhage—Epirubicin—pancreatic cancer	2.45e-05	0.000241	CcSEcCtD
Docetaxel—Hepatitis—Epirubicin—pancreatic cancer	2.45e-05	0.000241	CcSEcCtD
Docetaxel—Diarrhoea—Fluorouracil—pancreatic cancer	2.45e-05	0.00024	CcSEcCtD
Docetaxel—Hypoaesthesia—Epirubicin—pancreatic cancer	2.44e-05	0.000239	CcSEcCtD
Docetaxel—Pharyngitis—Epirubicin—pancreatic cancer	2.43e-05	0.000239	CcSEcCtD
Docetaxel—Urinary tract disorder—Epirubicin—pancreatic cancer	2.42e-05	0.000238	CcSEcCtD
Docetaxel—Oedema peripheral—Epirubicin—pancreatic cancer	2.41e-05	0.000237	CcSEcCtD
Docetaxel—Connective tissue disorder—Epirubicin—pancreatic cancer	2.41e-05	0.000236	CcSEcCtD
Docetaxel—Urethral disorder—Epirubicin—pancreatic cancer	2.4e-05	0.000236	CcSEcCtD
Docetaxel—Hepatobiliary disease—Doxorubicin—pancreatic cancer	2.39e-05	0.000235	CcSEcCtD
Docetaxel—Epistaxis—Doxorubicin—pancreatic cancer	2.38e-05	0.000234	CcSEcCtD
Docetaxel—Vomiting—Irinotecan—pancreatic cancer	2.37e-05	0.000233	CcSEcCtD
Docetaxel—Dizziness—Fluorouracil—pancreatic cancer	2.36e-05	0.000232	CcSEcCtD
Docetaxel—Visual impairment—Epirubicin—pancreatic cancer	2.36e-05	0.000232	CcSEcCtD
Docetaxel—Agranulocytosis—Doxorubicin—pancreatic cancer	2.36e-05	0.000231	CcSEcCtD
Docetaxel—Rash—Irinotecan—pancreatic cancer	2.35e-05	0.000231	CcSEcCtD
Docetaxel—Dermatitis—Irinotecan—pancreatic cancer	2.35e-05	0.000231	CcSEcCtD
Docetaxel—Headache—Irinotecan—pancreatic cancer	2.34e-05	0.00023	CcSEcCtD
Docetaxel—Erythema multiforme—Epirubicin—pancreatic cancer	2.32e-05	0.000228	CcSEcCtD
Docetaxel—Vomiting—Gemcitabine—pancreatic cancer	2.31e-05	0.000227	CcSEcCtD
Docetaxel—Rash—Gemcitabine—pancreatic cancer	2.29e-05	0.000225	CcSEcCtD
Docetaxel—Dermatitis—Gemcitabine—pancreatic cancer	2.29e-05	0.000225	CcSEcCtD
Docetaxel—Eye disorder—Epirubicin—pancreatic cancer	2.29e-05	0.000225	CcSEcCtD
Docetaxel—Haemoglobin—Doxorubicin—pancreatic cancer	2.28e-05	0.000224	CcSEcCtD
Docetaxel—Headache—Gemcitabine—pancreatic cancer	2.28e-05	0.000224	CcSEcCtD
Docetaxel—Flushing—Epirubicin—pancreatic cancer	2.27e-05	0.000223	CcSEcCtD
Docetaxel—Cardiac disorder—Epirubicin—pancreatic cancer	2.27e-05	0.000223	CcSEcCtD
Docetaxel—Vomiting—Fluorouracil—pancreatic cancer	2.27e-05	0.000223	CcSEcCtD
Docetaxel—Rhinitis—Doxorubicin—pancreatic cancer	2.27e-05	0.000223	CcSEcCtD
Docetaxel—Hepatitis—Doxorubicin—pancreatic cancer	2.27e-05	0.000223	CcSEcCtD
Docetaxel—Haemorrhage—Doxorubicin—pancreatic cancer	2.27e-05	0.000223	CcSEcCtD
Docetaxel—Hypoaesthesia—Doxorubicin—pancreatic cancer	2.25e-05	0.000222	CcSEcCtD
Docetaxel—Rash—Fluorouracil—pancreatic cancer	2.25e-05	0.000221	CcSEcCtD
Docetaxel—Dermatitis—Fluorouracil—pancreatic cancer	2.25e-05	0.000221	CcSEcCtD
Docetaxel—Pharyngitis—Doxorubicin—pancreatic cancer	2.25e-05	0.000221	CcSEcCtD
Docetaxel—Headache—Fluorouracil—pancreatic cancer	2.24e-05	0.00022	CcSEcCtD
Docetaxel—Urinary tract disorder—Doxorubicin—pancreatic cancer	2.24e-05	0.00022	CcSEcCtD
Docetaxel—Oedema peripheral—Doxorubicin—pancreatic cancer	2.23e-05	0.000219	CcSEcCtD
Docetaxel—Connective tissue disorder—Doxorubicin—pancreatic cancer	2.23e-05	0.000219	CcSEcCtD
Docetaxel—Angiopathy—Epirubicin—pancreatic cancer	2.22e-05	0.000218	CcSEcCtD
Docetaxel—Urethral disorder—Doxorubicin—pancreatic cancer	2.22e-05	0.000218	CcSEcCtD
Docetaxel—Nausea—Irinotecan—pancreatic cancer	2.22e-05	0.000218	CcSEcCtD
Docetaxel—Immune system disorder—Epirubicin—pancreatic cancer	2.21e-05	0.000217	CcSEcCtD
Docetaxel—Mediastinal disorder—Epirubicin—pancreatic cancer	2.21e-05	0.000217	CcSEcCtD
Docetaxel—Chills—Epirubicin—pancreatic cancer	2.2e-05	0.000216	CcSEcCtD
Docetaxel—Arrhythmia—Epirubicin—pancreatic cancer	2.19e-05	0.000215	CcSEcCtD
Docetaxel—Visual impairment—Doxorubicin—pancreatic cancer	2.18e-05	0.000215	CcSEcCtD
Docetaxel—Alopecia—Epirubicin—pancreatic cancer	2.16e-05	0.000213	CcSEcCtD
Docetaxel—Nausea—Gemcitabine—pancreatic cancer	2.16e-05	0.000212	CcSEcCtD
Docetaxel—Mental disorder—Epirubicin—pancreatic cancer	2.15e-05	0.000211	CcSEcCtD
Docetaxel—Erythema multiforme—Doxorubicin—pancreatic cancer	2.14e-05	0.000211	CcSEcCtD
Docetaxel—Malnutrition—Epirubicin—pancreatic cancer	2.13e-05	0.00021	CcSEcCtD
Docetaxel—Erythema—Epirubicin—pancreatic cancer	2.13e-05	0.00021	CcSEcCtD
Docetaxel—Nausea—Fluorouracil—pancreatic cancer	2.12e-05	0.000209	CcSEcCtD
Docetaxel—Eye disorder—Doxorubicin—pancreatic cancer	2.12e-05	0.000208	CcSEcCtD
Docetaxel—Flushing—Doxorubicin—pancreatic cancer	2.1e-05	0.000207	CcSEcCtD
Docetaxel—Cardiac disorder—Doxorubicin—pancreatic cancer	2.1e-05	0.000207	CcSEcCtD
Docetaxel—Dysgeusia—Epirubicin—pancreatic cancer	2.09e-05	0.000205	CcSEcCtD
Docetaxel—Back pain—Epirubicin—pancreatic cancer	2.06e-05	0.000203	CcSEcCtD
Docetaxel—Angiopathy—Doxorubicin—pancreatic cancer	2.06e-05	0.000202	CcSEcCtD
Docetaxel—Muscle spasms—Epirubicin—pancreatic cancer	2.05e-05	0.000201	CcSEcCtD
Docetaxel—Immune system disorder—Doxorubicin—pancreatic cancer	2.05e-05	0.000201	CcSEcCtD
Docetaxel—Mediastinal disorder—Doxorubicin—pancreatic cancer	2.04e-05	0.000201	CcSEcCtD
Docetaxel—Chills—Doxorubicin—pancreatic cancer	2.03e-05	0.0002	CcSEcCtD
Docetaxel—Arrhythmia—Doxorubicin—pancreatic cancer	2.02e-05	0.000199	CcSEcCtD
Docetaxel—Alopecia—Doxorubicin—pancreatic cancer	2e-05	0.000197	CcSEcCtD
Docetaxel—Mental disorder—Doxorubicin—pancreatic cancer	1.99e-05	0.000195	CcSEcCtD
Docetaxel—Malnutrition—Doxorubicin—pancreatic cancer	1.97e-05	0.000194	CcSEcCtD
Docetaxel—Erythema—Doxorubicin—pancreatic cancer	1.97e-05	0.000194	CcSEcCtD
Docetaxel—Anaemia—Epirubicin—pancreatic cancer	1.97e-05	0.000194	CcSEcCtD
Docetaxel—Dysgeusia—Doxorubicin—pancreatic cancer	1.93e-05	0.00019	CcSEcCtD
Docetaxel—Syncope—Epirubicin—pancreatic cancer	1.91e-05	0.000188	CcSEcCtD
Docetaxel—Leukopenia—Epirubicin—pancreatic cancer	1.91e-05	0.000188	CcSEcCtD
Docetaxel—Back pain—Doxorubicin—pancreatic cancer	1.91e-05	0.000188	CcSEcCtD
Docetaxel—Muscle spasms—Doxorubicin—pancreatic cancer	1.9e-05	0.000186	CcSEcCtD
Docetaxel—Palpitations—Epirubicin—pancreatic cancer	1.88e-05	0.000185	CcSEcCtD
Docetaxel—Loss of consciousness—Epirubicin—pancreatic cancer	1.87e-05	0.000184	CcSEcCtD
Docetaxel—Cough—Epirubicin—pancreatic cancer	1.86e-05	0.000183	CcSEcCtD
Docetaxel—Convulsion—Epirubicin—pancreatic cancer	1.85e-05	0.000182	CcSEcCtD
Docetaxel—Hypertension—Epirubicin—pancreatic cancer	1.84e-05	0.000181	CcSEcCtD
Docetaxel—Anaemia—Doxorubicin—pancreatic cancer	1.82e-05	0.000179	CcSEcCtD
Docetaxel—Arthralgia—Epirubicin—pancreatic cancer	1.82e-05	0.000178	CcSEcCtD
Docetaxel—Myalgia—Epirubicin—pancreatic cancer	1.82e-05	0.000178	CcSEcCtD
Docetaxel—Chest pain—Epirubicin—pancreatic cancer	1.82e-05	0.000178	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	1.8e-05	0.000177	CcSEcCtD
Docetaxel—Dry mouth—Epirubicin—pancreatic cancer	1.78e-05	0.000174	CcSEcCtD
Docetaxel—Syncope—Doxorubicin—pancreatic cancer	1.77e-05	0.000174	CcSEcCtD
Docetaxel—Leukopenia—Doxorubicin—pancreatic cancer	1.77e-05	0.000174	CcSEcCtD
Docetaxel—Confusional state—Epirubicin—pancreatic cancer	1.75e-05	0.000172	CcSEcCtD
Docetaxel—Palpitations—Doxorubicin—pancreatic cancer	1.74e-05	0.000171	CcSEcCtD
Docetaxel—Anaphylactic shock—Epirubicin—pancreatic cancer	1.74e-05	0.000171	CcSEcCtD
Docetaxel—Oedema—Epirubicin—pancreatic cancer	1.74e-05	0.000171	CcSEcCtD
Docetaxel—Loss of consciousness—Doxorubicin—pancreatic cancer	1.73e-05	0.00017	CcSEcCtD
Docetaxel—Infection—Epirubicin—pancreatic cancer	1.73e-05	0.00017	CcSEcCtD
Docetaxel—Cough—Doxorubicin—pancreatic cancer	1.72e-05	0.000169	CcSEcCtD
Docetaxel—Shock—Epirubicin—pancreatic cancer	1.71e-05	0.000168	CcSEcCtD
Docetaxel—Convulsion—Doxorubicin—pancreatic cancer	1.71e-05	0.000168	CcSEcCtD
Docetaxel—Nervous system disorder—Epirubicin—pancreatic cancer	1.71e-05	0.000168	CcSEcCtD
Docetaxel—Thrombocytopenia—Epirubicin—pancreatic cancer	1.7e-05	0.000167	CcSEcCtD
Docetaxel—Hypertension—Doxorubicin—pancreatic cancer	1.7e-05	0.000167	CcSEcCtD
Docetaxel—Tachycardia—Epirubicin—pancreatic cancer	1.7e-05	0.000167	CcSEcCtD
Docetaxel—Skin disorder—Epirubicin—pancreatic cancer	1.69e-05	0.000166	CcSEcCtD
Docetaxel—Chest pain—Doxorubicin—pancreatic cancer	1.68e-05	0.000165	CcSEcCtD
Docetaxel—Arthralgia—Doxorubicin—pancreatic cancer	1.68e-05	0.000165	CcSEcCtD
Docetaxel—Myalgia—Doxorubicin—pancreatic cancer	1.68e-05	0.000165	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	1.67e-05	0.000164	CcSEcCtD
Docetaxel—Anorexia—Epirubicin—pancreatic cancer	1.66e-05	0.000163	CcSEcCtD
Docetaxel—Dry mouth—Doxorubicin—pancreatic cancer	1.64e-05	0.000161	CcSEcCtD
Docetaxel—Hypotension—Epirubicin—pancreatic cancer	1.63e-05	0.00016	CcSEcCtD
Docetaxel—Confusional state—Doxorubicin—pancreatic cancer	1.62e-05	0.00016	CcSEcCtD
Docetaxel—Anaphylactic shock—Doxorubicin—pancreatic cancer	1.61e-05	0.000158	CcSEcCtD
Docetaxel—Oedema—Doxorubicin—pancreatic cancer	1.61e-05	0.000158	CcSEcCtD
Docetaxel—Infection—Doxorubicin—pancreatic cancer	1.6e-05	0.000157	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	1.59e-05	0.000156	CcSEcCtD
Docetaxel—Shock—Doxorubicin—pancreatic cancer	1.58e-05	0.000156	CcSEcCtD
Docetaxel—Nervous system disorder—Doxorubicin—pancreatic cancer	1.58e-05	0.000155	CcSEcCtD
Docetaxel—Thrombocytopenia—Doxorubicin—pancreatic cancer	1.58e-05	0.000155	CcSEcCtD
Docetaxel—Insomnia—Epirubicin—pancreatic cancer	1.57e-05	0.000155	CcSEcCtD
Docetaxel—Tachycardia—Doxorubicin—pancreatic cancer	1.57e-05	0.000154	CcSEcCtD
Docetaxel—Skin disorder—Doxorubicin—pancreatic cancer	1.56e-05	0.000154	CcSEcCtD
Docetaxel—Paraesthesia—Epirubicin—pancreatic cancer	1.56e-05	0.000154	CcSEcCtD
Docetaxel—Dyspnoea—Epirubicin—pancreatic cancer	1.55e-05	0.000152	CcSEcCtD
Docetaxel—Somnolence—Epirubicin—pancreatic cancer	1.55e-05	0.000152	CcSEcCtD
Docetaxel—Anorexia—Doxorubicin—pancreatic cancer	1.53e-05	0.000151	CcSEcCtD
Docetaxel—Dyspepsia—Epirubicin—pancreatic cancer	1.53e-05	0.000151	CcSEcCtD
Docetaxel—Decreased appetite—Epirubicin—pancreatic cancer	1.51e-05	0.000149	CcSEcCtD
Docetaxel—Hypotension—Doxorubicin—pancreatic cancer	1.5e-05	0.000148	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Epirubicin—pancreatic cancer	1.5e-05	0.000148	CcSEcCtD
Docetaxel—Fatigue—Epirubicin—pancreatic cancer	1.5e-05	0.000147	CcSEcCtD
Docetaxel—Pain—Epirubicin—pancreatic cancer	1.49e-05	0.000146	CcSEcCtD
Docetaxel—Constipation—Epirubicin—pancreatic cancer	1.49e-05	0.000146	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	1.47e-05	0.000144	CcSEcCtD
Docetaxel—Insomnia—Doxorubicin—pancreatic cancer	1.46e-05	0.000143	CcSEcCtD
Docetaxel—Paraesthesia—Doxorubicin—pancreatic cancer	1.45e-05	0.000142	CcSEcCtD
Docetaxel—Dyspnoea—Doxorubicin—pancreatic cancer	1.44e-05	0.000141	CcSEcCtD
Docetaxel—Feeling abnormal—Epirubicin—pancreatic cancer	1.43e-05	0.000141	CcSEcCtD
Docetaxel—Somnolence—Doxorubicin—pancreatic cancer	1.43e-05	0.000141	CcSEcCtD
Docetaxel—Gastrointestinal pain—Epirubicin—pancreatic cancer	1.42e-05	0.00014	CcSEcCtD
Docetaxel—Dyspepsia—Doxorubicin—pancreatic cancer	1.42e-05	0.000139	CcSEcCtD
Docetaxel—Decreased appetite—Doxorubicin—pancreatic cancer	1.4e-05	0.000138	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	1.39e-05	0.000137	CcSEcCtD
Docetaxel—Fatigue—Doxorubicin—pancreatic cancer	1.39e-05	0.000136	CcSEcCtD
Docetaxel—Constipation—Doxorubicin—pancreatic cancer	1.38e-05	0.000135	CcSEcCtD
Docetaxel—Pain—Doxorubicin—pancreatic cancer	1.38e-05	0.000135	CcSEcCtD
Docetaxel—Abdominal pain—Epirubicin—pancreatic cancer	1.38e-05	0.000135	CcSEcCtD
Docetaxel—Body temperature increased—Epirubicin—pancreatic cancer	1.38e-05	0.000135	CcSEcCtD
Docetaxel—Feeling abnormal—Doxorubicin—pancreatic cancer	1.33e-05	0.00013	CcSEcCtD
Docetaxel—Gastrointestinal pain—Doxorubicin—pancreatic cancer	1.32e-05	0.000129	CcSEcCtD
Docetaxel—Hypersensitivity—Epirubicin—pancreatic cancer	1.28e-05	0.000126	CcSEcCtD
Docetaxel—Abdominal pain—Doxorubicin—pancreatic cancer	1.27e-05	0.000125	CcSEcCtD
Docetaxel—Body temperature increased—Doxorubicin—pancreatic cancer	1.27e-05	0.000125	CcSEcCtD
Docetaxel—Asthenia—Epirubicin—pancreatic cancer	1.25e-05	0.000123	CcSEcCtD
Docetaxel—Pruritus—Epirubicin—pancreatic cancer	1.23e-05	0.000121	CcSEcCtD
Docetaxel—Diarrhoea—Epirubicin—pancreatic cancer	1.19e-05	0.000117	CcSEcCtD
Docetaxel—Hypersensitivity—Doxorubicin—pancreatic cancer	1.19e-05	0.000117	CcSEcCtD
Docetaxel—Asthenia—Doxorubicin—pancreatic cancer	1.16e-05	0.000114	CcSEcCtD
Docetaxel—Dizziness—Epirubicin—pancreatic cancer	1.15e-05	0.000113	CcSEcCtD
Docetaxel—Pruritus—Doxorubicin—pancreatic cancer	1.14e-05	0.000112	CcSEcCtD
Docetaxel—Vomiting—Epirubicin—pancreatic cancer	1.11e-05	0.000109	CcSEcCtD
Docetaxel—Diarrhoea—Doxorubicin—pancreatic cancer	1.1e-05	0.000108	CcSEcCtD
Docetaxel—Rash—Epirubicin—pancreatic cancer	1.1e-05	0.000108	CcSEcCtD
Docetaxel—Dermatitis—Epirubicin—pancreatic cancer	1.1e-05	0.000108	CcSEcCtD
Docetaxel—Headache—Epirubicin—pancreatic cancer	1.09e-05	0.000107	CcSEcCtD
Docetaxel—Dizziness—Doxorubicin—pancreatic cancer	1.06e-05	0.000105	CcSEcCtD
Docetaxel—Nausea—Epirubicin—pancreatic cancer	1.03e-05	0.000102	CcSEcCtD
Docetaxel—Vomiting—Doxorubicin—pancreatic cancer	1.02e-05	0.000101	CcSEcCtD
Docetaxel—Rash—Doxorubicin—pancreatic cancer	1.02e-05	9.98e-05	CcSEcCtD
Docetaxel—Dermatitis—Doxorubicin—pancreatic cancer	1.01e-05	9.97e-05	CcSEcCtD
Docetaxel—Headache—Doxorubicin—pancreatic cancer	1.01e-05	9.91e-05	CcSEcCtD
Docetaxel—Nausea—Doxorubicin—pancreatic cancer	9.56e-06	9.4e-05	CcSEcCtD
Docetaxel—EGFR—Developmental Biology—SRC—pancreatic cancer	3.26e-06	5.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOTCH3—pancreatic cancer	3.25e-06	5.05e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.22e-06	5.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—HRAS—pancreatic cancer	3.22e-06	5e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TYMP—pancreatic cancer	3.21e-06	4.99e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	3.21e-06	4.98e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CTNNB1—pancreatic cancer	3.19e-06	4.95e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—VEGFA—pancreatic cancer	3.18e-06	4.93e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TERT—pancreatic cancer	3.18e-06	4.93e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CG—pancreatic cancer	3.17e-06	4.92e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	3.15e-06	4.9e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	3.15e-06	4.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—STAT3—pancreatic cancer	3.14e-06	4.88e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CTNNB1—pancreatic cancer	3.14e-06	4.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—AKT1—pancreatic cancer	3.14e-06	4.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—NRAS—pancreatic cancer	3.14e-06	4.87e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—STK11—pancreatic cancer	3.12e-06	4.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—BCL2L1—pancreatic cancer	3.11e-06	4.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PTEN—pancreatic cancer	3.11e-06	4.82e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—STK11—pancreatic cancer	3.1e-06	4.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TSC2—pancreatic cancer	3.09e-06	4.8e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	3.09e-06	4.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CNR1—pancreatic cancer	3.08e-06	4.79e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PTEN—pancreatic cancer	3.06e-06	4.75e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PPARG—pancreatic cancer	3.06e-06	4.75e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—TYMS—pancreatic cancer	3.05e-06	4.74e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HIF1A—pancreatic cancer	3.04e-06	4.72e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TSC2—pancreatic cancer	3.03e-06	4.71e-05	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—AKT1—pancreatic cancer	3.03e-06	4.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TERT—pancreatic cancer	2.99e-06	4.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CG—pancreatic cancer	2.99e-06	4.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PTEN—pancreatic cancer	2.98e-06	4.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GCG—pancreatic cancer	2.98e-06	4.62e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—APOE—pancreatic cancer	2.97e-06	4.61e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—TYMS—pancreatic cancer	2.95e-06	4.59e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.94e-06	4.56e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TGFB1—pancreatic cancer	2.92e-06	4.53e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.91e-06	4.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—SRC—pancreatic cancer	2.88e-06	4.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HIF1A—pancreatic cancer	2.86e-06	4.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TSC2—pancreatic cancer	2.86e-06	4.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AGTR1—pancreatic cancer	2.84e-06	4.41e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—SRC—pancreatic cancer	2.84e-06	4.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NFKBIA—pancreatic cancer	2.82e-06	4.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STK11—pancreatic cancer	2.8e-06	4.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—APOE—pancreatic cancer	2.79e-06	4.34e-05	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—pancreatic cancer	2.79e-06	4.33e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CD—pancreatic cancer	2.79e-06	4.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NRAS—pancreatic cancer	2.77e-06	4.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—SRC—pancreatic cancer	2.77e-06	4.3e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOTCH1—pancreatic cancer	2.74e-06	4.25e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—STAT3—pancreatic cancer	2.74e-06	4.25e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NRAS—pancreatic cancer	2.73e-06	4.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—pancreatic cancer	2.72e-06	4.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—EGF—pancreatic cancer	2.7e-06	4.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—pancreatic cancer	2.7e-06	4.19e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TYMS—pancreatic cancer	2.69e-06	4.17e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.68e-06	4.16e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TYMS—pancreatic cancer	2.66e-06	4.14e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—NRAS—pancreatic cancer	2.66e-06	4.13e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGF—pancreatic cancer	2.65e-06	4.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CD—pancreatic cancer	2.63e-06	4.08e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.61e-06	4.06e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GLP1R—pancreatic cancer	2.59e-06	4.02e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.59e-06	4.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOTCH1—pancreatic cancer	2.58e-06	4.01e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—DPYD—pancreatic cancer	2.55e-06	3.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDH1—pancreatic cancer	2.51e-06	3.9e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—EGF—pancreatic cancer	2.49e-06	3.87e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—pancreatic cancer	2.49e-06	3.86e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—APOE—pancreatic cancer	2.48e-06	3.86e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CD44—pancreatic cancer	2.48e-06	3.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SMAD4—pancreatic cancer	2.45e-06	3.81e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CB—pancreatic cancer	2.43e-06	3.77e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC2A2—pancreatic cancer	2.42e-06	3.76e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—pancreatic cancer	2.41e-06	3.74e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—APOE—pancreatic cancer	2.4e-06	3.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CD—pancreatic cancer	2.4e-06	3.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HES1—pancreatic cancer	2.39e-06	3.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—pancreatic cancer	2.38e-06	3.7e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GCG—pancreatic cancer	2.38e-06	3.7e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CD—pancreatic cancer	2.35e-06	3.65e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.35e-06	3.65e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—pancreatic cancer	2.35e-06	3.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—pancreatic cancer	2.3e-06	3.56e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CB—pancreatic cancer	2.29e-06	3.56e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—pancreatic cancer	2.29e-06	3.56e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.27e-06	3.53e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ARG2—pancreatic cancer	2.27e-06	3.52e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CG—pancreatic cancer	2.24e-06	3.48e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—STK11—pancreatic cancer	2.24e-06	3.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CD—pancreatic cancer	2.22e-06	3.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL8—pancreatic cancer	2.2e-06	3.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PIK3CA—pancreatic cancer	2.19e-06	3.4e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.19e-06	3.4e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—APOE—pancreatic cancer	2.19e-06	3.39e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CG—pancreatic cancer	2.17e-06	3.37e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—APOE—pancreatic cancer	2.17e-06	3.36e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARG—pancreatic cancer	2.16e-06	3.36e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PIK3CA—pancreatic cancer	2.16e-06	3.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PIK3CA—pancreatic cancer	2.1e-06	3.27e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTEN—pancreatic cancer	2.1e-06	3.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TERT—pancreatic cancer	2.1e-06	3.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CB—pancreatic cancer	2.09e-06	3.25e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARG—pancreatic cancer	2.09e-06	3.25e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CB—pancreatic cancer	2.05e-06	3.18e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—pancreatic cancer	2.03e-06	3.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—pancreatic cancer	2.03e-06	3.15e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—pancreatic cancer	2.03e-06	3.15e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HIF1A—pancreatic cancer	2e-06	3.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TSC2—pancreatic cancer	2e-06	3.11e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—pancreatic cancer	2e-06	3.1e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.98e-06	3.08e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CG—pancreatic cancer	1.97e-06	3.06e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CD—pancreatic cancer	1.97e-06	3.06e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APOE—pancreatic cancer	1.96e-06	3.04e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	1.95e-06	3.04e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—pancreatic cancer	1.95e-06	3.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CB—pancreatic cancer	1.93e-06	3e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TYMS—pancreatic cancer	1.92e-06	2.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KDR—pancreatic cancer	1.92e-06	2.98e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—pancreatic cancer	1.91e-06	2.97e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CD—pancreatic cancer	1.91e-06	2.96e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARG—pancreatic cancer	1.9e-06	2.96e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARG—pancreatic cancer	1.89e-06	2.93e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CD44—pancreatic cancer	1.87e-06	2.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTNNB1—pancreatic cancer	1.86e-06	2.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NFKBIA—pancreatic cancer	1.82e-06	2.83e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CTNNB1—pancreatic cancer	1.82e-06	2.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTEN—pancreatic cancer	1.81e-06	2.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOTCH1—pancreatic cancer	1.81e-06	2.81e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GCG—pancreatic cancer	1.8e-06	2.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—pancreatic cancer	1.79e-06	2.78e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTEN—pancreatic cancer	1.77e-06	2.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CG—pancreatic cancer	1.77e-06	2.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NRAS—pancreatic cancer	1.77e-06	2.74e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—pancreatic cancer	1.76e-06	2.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EGF—pancreatic cancer	1.75e-06	2.71e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CD—pancreatic cancer	1.73e-06	2.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—pancreatic cancer	1.72e-06	2.67e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	1.72e-06	2.67e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CB—pancreatic cancer	1.72e-06	2.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CTNNB1—pancreatic cancer	1.71e-06	2.66e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—pancreatic cancer	1.7e-06	2.64e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—STK11—pancreatic cancer	1.69e-06	2.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—SRC—pancreatic cancer	1.68e-06	2.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTEN—pancreatic cancer	1.67e-06	2.59e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CB—pancreatic cancer	1.66e-06	2.58e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—pancreatic cancer	1.65e-06	2.56e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SRC—pancreatic cancer	1.64e-06	2.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—pancreatic cancer	1.62e-06	2.51e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRAS—pancreatic cancer	1.61e-06	2.51e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.6e-06	2.48e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—pancreatic cancer	1.58e-06	2.46e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRAS—pancreatic cancer	1.58e-06	2.46e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.57e-06	2.44e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—APOE—pancreatic cancer	1.57e-06	2.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CD—pancreatic cancer	1.55e-06	2.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—SRC—pancreatic cancer	1.55e-06	2.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—pancreatic cancer	1.52e-06	2.36e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CB—pancreatic cancer	1.51e-06	2.35e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	1.5e-06	2.33e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—pancreatic cancer	1.5e-06	2.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—pancreatic cancer	1.49e-06	2.32e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.49e-06	2.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRAS—pancreatic cancer	1.49e-06	2.31e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—pancreatic cancer	1.48e-06	2.3e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTEN—pancreatic cancer	1.48e-06	2.3e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CA—pancreatic cancer	1.48e-06	2.3e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—pancreatic cancer	1.47e-06	2.29e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFB1—pancreatic cancer	1.47e-06	2.28e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TYMS—pancreatic cancer	1.45e-06	2.26e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—pancreatic cancer	1.44e-06	2.24e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTEN—pancreatic cancer	1.44e-06	2.23e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	1.41e-06	2.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CA—pancreatic cancer	1.4e-06	2.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—pancreatic cancer	1.39e-06	2.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—pancreatic cancer	1.39e-06	2.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFB1—pancreatic cancer	1.38e-06	2.15e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARG—pancreatic cancer	1.36e-06	2.12e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—pancreatic cancer	1.36e-06	2.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CB—pancreatic cancer	1.35e-06	2.1e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTEN—pancreatic cancer	1.31e-06	2.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL8—pancreatic cancer	1.3e-06	2.02e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTEN—pancreatic cancer	1.29e-06	2.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—pancreatic cancer	1.29e-06	2.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—pancreatic cancer	1.28e-06	1.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CA—pancreatic cancer	1.28e-06	1.98e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CA—pancreatic cancer	1.25e-06	1.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASP3—pancreatic cancer	1.24e-06	1.93e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	1.24e-06	1.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—pancreatic cancer	1.21e-06	1.88e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—pancreatic cancer	1.21e-06	1.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CTNNB1—pancreatic cancer	1.2e-06	1.86e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOE—pancreatic cancer	1.18e-06	1.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—pancreatic cancer	1.18e-06	1.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CA—pancreatic cancer	1.18e-06	1.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—pancreatic cancer	1.18e-06	1.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTEN—pancreatic cancer	1.17e-06	1.82e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—pancreatic cancer	1.16e-06	1.8e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CD44—pancreatic cancer	1.15e-06	1.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—pancreatic cancer	1.14e-06	1.77e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GCG—pancreatic cancer	1.11e-06	1.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—pancreatic cancer	1.09e-06	1.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SRC—pancreatic cancer	1.08e-06	1.68e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	1.08e-06	1.68e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—pancreatic cancer	1.07e-06	1.67e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.07e-06	1.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—pancreatic cancer	1.06e-06	1.64e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CA—pancreatic cancer	1.05e-06	1.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—pancreatic cancer	1.05e-06	1.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRAS—pancreatic cancer	1.04e-06	1.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—pancreatic cancer	1.04e-06	1.62e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—STK11—pancreatic cancer	1.04e-06	1.62e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARG—pancreatic cancer	1.03e-06	1.6e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—pancreatic cancer	1.02e-06	1.59e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CA—pancreatic cancer	1.01e-06	1.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—pancreatic cancer	9.72e-07	1.51e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFB1—pancreatic cancer	9.7e-07	1.51e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—pancreatic cancer	9.62e-07	1.49e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CD—pancreatic cancer	9.37e-07	1.46e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTEN—pancreatic cancer	9.36e-07	1.45e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CA—pancreatic cancer	9.21e-07	1.43e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	9.13e-07	1.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—pancreatic cancer	8.98e-07	1.39e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TYMS—pancreatic cancer	8.95e-07	1.39e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—pancreatic cancer	8.55e-07	1.33e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—pancreatic cancer	8.27e-07	1.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CA—pancreatic cancer	8.25e-07	1.28e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CB—pancreatic cancer	8.17e-07	1.27e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—pancreatic cancer	8.09e-07	1.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—pancreatic cancer	7.98e-07	1.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—pancreatic cancer	7.63e-07	1.19e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—pancreatic cancer	7.52e-07	1.17e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—pancreatic cancer	7.46e-07	1.16e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOE—pancreatic cancer	7.28e-07	1.13e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTEN—pancreatic cancer	7.06e-07	1.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—pancreatic cancer	6.74e-07	1.05e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	6.6e-07	1.03e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	6.57e-07	1.02e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARG—pancreatic cancer	6.34e-07	9.85e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	5.77e-07	8.97e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—pancreatic cancer	5.39e-07	8.37e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	5.03e-07	7.82e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4.99e-07	7.75e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CA—pancreatic cancer	4.98e-07	7.74e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTEN—pancreatic cancer	4.35e-07	6.76e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—pancreatic cancer	4.07e-07	6.32e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	3.07e-07	4.77e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.51e-07	3.89e-06	CbGpPWpGaD
